Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
33,490 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Thymosin-ɑ1 for people with chronic hepatitis B.
Naing C, Ni H, Aung HH, Aye SN, Nikolova D, Poovorawan Y, Pavlov C. · Cochrane Database Syst Rev · 2026 · cited 1 timesmeta-analysis, systematic review
- Transplantation of Hepatitis B Surface Antigen Positive or Viremic Kidneys: A Systematic Review and Meta-Analysis.
Ahuja D, Concepcion BP, Yuan Y, Forbes R, Rogers JL, Te HS, El Kassis Y. · Clin Transplant · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- The Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334, A Novel Next-Generation Hepatitis B Capsid Assembly Modulator.
Gane EJ, Schwabe C, Ghicavii N, Ticot C, Zomorodi K, Knox SJ, Kitrinos KM, Yan R, Liu J, Wang G, Gaggar A, Jucov A. · J Viral Hepat · 2026 · cited 0 timesOpen accessclinical trial, phase i, randomized controlled trial
- Prevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis.
Maliki I, Webb EJD, Ada RA, Dawkins B, Lim AG. · J Viral Hepat · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B.
Asselah T, Kakuda TN, Kulke S, Walenta E, Halter RJ, Ariyawansa J, Verheijden S, Lenz O, Aguilar Z, Lonjon-Domanec I, Biermer M. · J Viral Hepat · 2026 · cited 0 timesOpen accessmulticenter study, clinical trial, phase i
- Hepatitis B among hospital nurses worldwide: a meta-analysis of seroprevalence studies.
Li F, Wang J, Zhang W. · Vaccine · 2026 · cited 0 timesmeta-analysis, systematic review
- Risk factors for postpartum alanine aminotransferase elevation in women with chronic hepatitis B infection: a systematic review and meta-analysis.
Yao C, Gao X, Zhu Y, Zhang X, Dai S, Wang J, Chen Y, Zou H. · Front Public Health · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Safety, Tolerability and Antiviral Activity of GST-HG131 in Chronic Hepatitis B: A Randomized, Double-Blind Phase IIa Study.
Guo Y, Xu Z, Li Y, Mao J, Zhang T, Li Y, Meng F, Fu J, Ji D, Ji Y, Cheng Y, Zhang M, Zhang X, Sun Y, Huang Z, Cai D, Wu W, Yan W, Yan X, Li G, Hou J, Zhang G, Wang FS. · Liver Int · 2026 · cited 1 timesclinical trial, phase ii, randomized controlled trial
- ALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury.
Agarwal K, Forton D, Zen Y, Wu M, Lin TI, Le K, Chanda S, Blatt L, Fry J, Gane E. · J Viral Hepat · 2026 · cited 0 timesclinical trial, phase i, randomized controlled trial
- Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients.
Kudaravalli S, Yan T, Tseng CH, Hsu YC, Li X, Wu Y, Chen B, Gao X, Gao S, Ren D, Qian X, Sands W, Cheung R, Nguyen MH. · J Viral Hepat · 2026 · cited 0 timesmeta-analysis, systematic review
- Interventions to Increase Hepatitis B Testing Uptake Amongst Detained Populations: A Systematic Review.
Kesavan SM, Khan G, Jack K, Martello E, Morling JR, Leonardi-Bee J. · J Viral Hepat · 2026 · cited 0 timesmeta-analysis, systematic review
- Impact of resolved hepatitis B virus infection on clinical outcomes in patients with diffuse large B-cell lymphoma: a supplementary analysis of JCOG0601.
Hagiwara S, Kusumoto S, Machida R, Ohmachi K, Makiyama J, Munakata W, Ando K, Kinoshita T, Tsukasaki K, Nagai H, Maruyama D. · Int J Hematol · 2026 · cited 0 timesclinical trial, phase iii, clinical trial, phase ii
- A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction.
Jin X, Tang Y, Ma Y, Li M, Gao Y. · Front Immunol · 2026 · cited 1 timesOpen accesssystematic review, systematic-review
- Finite Versus Indefinite Nucleos(t)ide Analogue Therapy in HBeAg‑Negative Chronic Hepatitis B: Meta‑Analysis of Randomized Trials.
Gomez DP, Hababag WF. · J Viral Hepat · 2026 · cited 0 timesmeta-analysis, comparative study
- Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
Hou J, Lim SG, Buti M, Yuen MF, Gane E, Lampertico P, Terrault N, Nguyen H, Yim HJ, Xie Q, Lin J, Qiu Y, Jeng WJ, Heo J, Peng CY, Chen CH, Chuang WL, Xie Y, Hlebowicz M, Idriz N, Mehta R, Agarwal K, Gomes da Silva MM, Franca A, Cernat R, Leerapun A, Coffin CS, Gadano A, Andreone P, Fujiyama S, Sevastianos V, Suzuki Y, Ratziu V, Riachi G, Stocker H, Lim TH, Asselah T, Tanaka Y, Holmes J, Liang X, Cremer J, Lukić T, Plein H, Quinn G, Tao Y, Paff M, Theodore D, Elston R, B-Well Study Group. · N Engl J Med · 2026 · cited 24 timesclinical trial, phase iii, multicenter study
- Prevalence of HIV and hepatitis B co-infection in Nigeria: a systematic review and meta-analysis.
Bagayang JY, Abaate TJ, Danbaki KE, Prince AN, Chinyere N. · BMC Infect Dis · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Efficacy of antiviral therapy in adults with chronic hepatitis B according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis.
Im YR, Chen SE, Jagdish R, Yucuma D, Rakover A, Warsop ZI, Chou R, Easterbrook P, Shimakawa Y. · Lancet Gastroenterol Hepatol · 2026 · cited 4 timesmeta-analysis, research support, non-u.s. gov't
- Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B.
Gane EJ, Chen CY, Tseng CH, Lin CY, Roberts SK, Tedesco D, Abramov F, Zhang F, Odegard JM, Wallin JJ, Shaik NA, Chew T, Lad L, Wang AY, Balsitis S, Fletcher SP, Lau AH, Chuang WL, Agarwal K. · Liver Int · 2026 · cited 0 timesresearch support, non-u.s. gov't, multicenter study
- Immunogenicity of Two Versus Three Doses of Hepatitis B Vaccine When Administered to Children Aged 2-18 Months: A Randomized Clinical Trial.
Kegbevi KB, Febriani Y, Sauvageau C, Ursu MM, Quach C, Desjardins M, Bestman-Smith J, Gilca V, Brousseau N. · J Infect Dis · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.
Cheng C, Xie Q, Gane E, Morano Amado LE, Yang SS, Zhang W, Jia J, Asselah T, Kao JH, Peng CY, Su WW, Tanwandee T, Liang X, Catanese MT, Chen E, Chughlay F, Das S, Glavini K, Guerreiro N, Huang Y, Kazma R, Liang Y, McGeown C, Patil A, Upmanyu R, Wat C, Yuen MF, Hou J, Piranga Study Group. · JHEP Rep · 2026 · cited 0 timesOpen accessclinical trial, phase ii, randomized controlled trial
- A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs.
Jeng WJ, Chu CJ, Leerapun A, Avihingsanon A, Zeuzem S, Bourgeois S, Yuen MF, Romero-Gomez M, Yang SS, Cravcenco C, Salaun B, Shi M, Vassilev V, Kim JH, Swinnen K, and the TH HBV VV-001 Study Group. · Hepatol Commun · 2026 · cited 0 timesOpen accessclinical trial, phase ii, clinical trial, phase i
- Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis.
Yucuma D, Rakover A, Warsop ZI, Im YR, Chen SE, Jagdish R, Ndow G, Lemoine M, Desalegn H, Johannessen A, Yang HI, Tanaka Y, Chou R, Easterbrook P, Shimakawa Y. · Lancet Gastroenterol Hepatol · 2026 · cited 1 timesmeta-analysis, research support, non-u.s. gov't
- Hepatitis B Virus Reactivation Risk With IL-17, IL-23/IL-12, or JAK Inhibitors: A Systematic Review and Meta-Analysis.
Alhalabi M, Alshiekh HA. · Liver Int · 2026 · cited 1 timesmeta-analysis, systematic review
- Seroprevalence and Molecular Epidemiology of Hepatitis B and D Viruses in Mauritania: a Systematic Review and Meta-Analysis.
Cheikh Bouna SM, Abdellah NS, Kamal H, Hemeyine M, Houmeida A, Stephenson VM, Ezzikouri S, Aleman S, Aboudkhil S. · J Epidemiol Glob Health · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Transmission Risk of Intentional Transplantation of Kidneys From Donors With Active Hepatitis B to Recipients Without Active Hepatitis B: A Systematic Review and Meta-Analysis.
Waller KMJ, De La Mata N, Hedley JA, Sharma T, Davies R, Garrett E, White S, Rawlinson W, Stelzer-Braid S, Wyburn K, Webster AC. · Transplantation · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.